Aldakhil Mohammed, Alsanea Nasser
Surgery Department, College of Medicine, Qassim University, Al'Qassim-Saudi Arabia.
Surgery Department, College of Medicine, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
J Surg Case Rep. 2025 May 22;2025(5):rjaf332. doi: 10.1093/jscr/rjaf332. eCollection 2025 May.
Patients with familial adenomatous polyposis (FAP) or ulcerative colitis (UC) are at increased risk of colorectal cancer (CRC), making surgical decision-making complex. This case series reviews six patients with FAP or UC who developed CRC and underwent ileal pouch-anal anastomosis (IPAA). Two patients with stage III CRC developed metastases, while the remaining four with stage I/II had no recurrence. IPAA is feasible in stage I/II CRC regardless of tumor location. For stage III colon cancer, total proctocolectomy (TPC) with IPAA followed by adjuvant chemotherapy is appropriate. In stage III rectal cancer more than 2 cm from the dentate line, IPAA can follow total neoadjuvant treatment (TNT). For tumors within 2 cm of the dentate line, TPC with end ileostomy is advised. IPAA may be contraindicated in cases with severe proctitis due to bleeding risk or radiation intolerance. Overall, IPAA is a suitable option for selected FAP or UC patients with CRC.
患有家族性腺瘤性息肉病(FAP)或溃疡性结肠炎(UC)的患者患结直肠癌(CRC)的风险增加,这使得手术决策变得复杂。本病例系列回顾了6例患有FAP或UC并发展为CRC且接受回肠储袋肛管吻合术(IPAA)的患者。2例III期CRC患者发生了转移,而其余4例I/II期患者无复发。无论肿瘤位置如何,IPAA在I/II期CRC中都是可行的。对于III期结肠癌,行IPAA的全直肠系膜切除术(TPC)并辅以辅助化疗是合适的。对于距齿状线超过2 cm的III期直肠癌,IPAA可在新辅助治疗(TNT)后进行。对于距齿状线2 cm以内的肿瘤,建议行TPC并末端回肠造口术。由于出血风险或放疗耐受性差,IPAA在严重直肠炎的情况下可能是禁忌的。总体而言,IPAA是部分患有CRC的FAP或UC患者的合适选择。